Publicaciones (11) Publicaciones de Eva Molina Buey

2019

  1. Management and 1-year outcomes of patients with newly diagnosed atrial fibrillation and chronic kidney disease: Results from the prospective garfield-af registry

    Journal of the American Heart Association, Vol. 8, Núm. 3

2018

  1. Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry

    Indian Heart Journal, Vol. 70, Núm. 6, pp. 828-835

2017

  1. Inducing heat shock protein 70 expression provides a robust antithrombotic effect with minimal bleeding risk

    Thrombosis and Haemostasis, Vol. 117, Núm. 9, pp. 1722-1729

2016

  1. Comparison of international normalized ratio audit parameters in patients enrolled in GARFIELD-AF and treated with vitamin K antagonists

    British Journal of Haematology, Vol. 174, Núm. 4, pp. 610-623

  2. Hsp70 protects from stroke in atrial fibrillation patients by preventing thrombosis without increased bleeding risk

    Cardiovascular Research, Vol. 110, Núm. 3, pp. 309-318

  3. Short Leukocyte Telomere Length Is Associated with Cardioembolic Stroke Risk in Patients with Atrial Fibrillation

    Stroke, Vol. 47, Núm. 3, pp. 863-865

2012

  1. Is EPCR a multi-ligand receptor? Pros and cons

    Thrombosis and Haemostasis, Vol. 107, Núm. 5, pp. 815-826

  2. Receptor of activated protein C promotes metastasis and correlates with clinical outcome in lung adenocarcinoma

    American Journal of Respiratory and Critical Care Medicine, Vol. 186, Núm. 1, pp. 96-105

2010

  1. VEGF121b and VEGF165b are weakly angiogenic isoforms of VEGF-A

    Molecular Cancer, Vol. 9

2008

  1. The functional properties of a truncated form of endothelial cell protein C receptor generated by alternative splicing

    Haematologica, Vol. 93, Núm. 6, pp. 878-884

2002

  1. Differential effects of 2C9*3 and 2C9*2 variants of cytochrome P-450 CYP2C9 on sensitivity to acenocoumarol

    Blood, Vol. 99, Núm. 11, pp. 4237-4239